Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration.

As radiopharmaceutical therapies gain momentum, new challenges are emerging in how they’re administered—especially around ...

Home Bargains has become a favourite spot for savvy shoppers looking to get their hands on top beauty bargains without breaking the bank. Premium brands occasionally make an appearance in-store at ...

Home Bargains has become a favourite spot for savvy shoppers looking to get their hands on top beauty bargains without ...

Merck secures U.S. Patent Office backing in its legal battle with Halozyme over Keytruda's injectable version. Read more here ...

New data from two clinical studies of the investigational use of Sarclisa administered subcutaneously via an on-body injector in relapsed or refractory multiple myeloma support the potential use of ...

The new offering, designed specifically for prefilled syringes used in various applications, complements its 1 mL ImProject ...

W. L. Gore & Associates, Inc. ("Gore"), a global materials science company, recently announced the commercial launch of the 0 ...

In the last month, the FDA has granted interchangeability status to additional adalimumab biosimilars.  Biosimilars with an ...

Samsung Bioepis and Organon shared that the Food and Drug Administration has designated the Hadlima (adalimumab-bwwd) high- ...

New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via an investigational on-body injector shortened treatment time to minutes with similar efficacy and safety ...